Medical device IPOs have recently begun a modest resurgence, with four US device start-ups closing IPOs since the beginning of the year, and three more pending completion. In the chart below, we compared the average step-up multiples (these are calculated by dividing the pre- and post-money IPO valuations by the private money raised: a proxy for average private valuation) of these types of deals.
Notably, all the IPOs so far this year fetched post-money caps of well over $200 million, and the post-money cap-to-private...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?